Target
Retinoic acid receptor alpha [200-419]
Ligand
BDBM36811
Substrate
n/a
Meas. Tech.
Competitive Assay
pH
8±0
Temperature
277.15±0 K
Ki
2.5±0.0 nM
Citation
 Géhin, MVivat, VWurtz, JMLosson, RChambon, PMoras, DGronemeyer, H Structural basis for engineering of retinoic acid receptor isotype-selective agonists and antagonists. Chem Biol 6:519-29 (1999) [PubMed]  Article 
Target
Name:
Retinoic acid receptor alpha [200-419]
Synonyms:
NR1B1 | Nuclear receptor subfamily 1 group B member 1 | RAR-alpha | RARA | RARA_HUMAN | Retinoic Acid Receptor, alpha
Type:
Ligand-binding domain
Mol. Mass.:
24746.59
Organism:
Homo sapiens (Human)
Description:
P10276[200-419]
Residue:
220
Sequence:
PALCQLGKYTTNNSSEQRVSLDIDLWDKFSELSTKCIIKTVEFAKQLPGFTTLTIADQITLLKAACLDILILRICTRYTPEQDTMTFSDGLTLNRTQMHNAGFGPLTDLVFAFANQLLPLEMDDAETGLLSAICLICGDRQDLEQPDRVDMLQEPLLEALKVYVRKRRPSRPHMFPKMLMKITDLRSISAKGAERVITLKMEIPGSMPPLIQEMLENSEG
  
Inhibitor
Name:
BDBM36811
Synonyms:
BMS614
Type:
Small organic molecule
Emp. Form.:
C29H24N2O3
Mol. Mass.:
448.5125
SMILES:
CC1(C)CC=C(c2cnc3ccccc3c2)c2cc(ccc12)C(=O)Nc1ccc(cc1)C(O)=O |t:4|
Structure:
Search PDB for entries with ligand similarity: